The Controversial Pink Pill That Boosts Female Sexual Desire | WSJ [6gid2PyxE9X]

The Controversial Pink Pill That Boosts Female Sexual Desire | WSJ [6gid2PyxE9X]

| 1h 28m 28s | Video has closed captioning.

The U.S. Food and Drug Administration has approved Flibanserin, the first prescription drug to boost sexual drive in women. Developed by a small company in North Carolina called Sprout Pharmaceuticals, Addyi is marketed as a drug for women with hypoactive sex drive disorder that has been rejected twice before. WSJ’s Mark Kelly reports on the potential side effects and covers the controversy behind the pink pill. 0:00 Flibanserin, explained 0:38 Potential side effects 0:50 Controversy behind the drug #FDA #Drug #WSJ #male enhancement exposed #rx gold male enhancement pills #do penis enlargment pills work